Project: TRANSLOCATION-transfer

Acronym TT (Reference Number: JPIAMR_2018_N027)
Duration 01/01/2019 - 31/03/2020
Project Topic There is an urgent need for discovery and development of new drugs to combat multi-resistant organisms. The search for new drugs is cumbersome, particularly because the current business model for antibiotics in the pharmaceutical industry has been stalled because of the poor return on investment. In response to the pharmaceutical industry stepping back from antibiotic discovery, multiple public efforts, including the JPIAMR and IMI ND4BB, as well as the efforts of Biomedical Science (BMS) European Research Infrastructures community have stepped in to fill the gap. In this project, the TT network will set up a knowledge sharing network, Translocation-Transfer bringing together experts from with two major publically funded programs, with the goal to improve the process of academically driven antibiotic drug discovery by capitalising on recently gained insights into a key bottleneck in anti-bacterial research, namely how compound penetration properties determine efficacy and resistance properties. Three existing communities forming the TT network are: 1) the partners associated with the multinational program Translocation (www.translocation.eu), part of IMI ND4BB; 2) partner sites from EU-OPENSCREEN, the European Research Infrastructure for chemical biology and screening (www.eu-openscreen.eu); 3) partners from the wider global community working on AMR issues and research. Translocation (1/2013-6/2018) was one of the largest antibiotic research programs in the world specifically devoted to understanding and to devising ways of increasing antibiotic penetration into bacteria. EUOPENSCREEN began operations in April 2018 and from 2019 onwards will run some 50 chemical biology and academic drug discovery projects per year, across a network of 25 screening sites, based in eight European countries on behalf of users from across Europe. It is anticipated that at least 20% of EU-OPENSCREEN projects will involve antibiotic drug discovery element. The initial goal of the TT network will be to transfer knowledge between Translocation and EU-OPENSCREEN to fully incorporate compound permeation and efflux considerations into academic antibiotic drug discovery. We have the active participation of the Pew Charitable Trust, which will contribute to the long-term systematic dissemination of findings from the co-funded funded Translocation project to help academic antibiotic drug discovery efforts on a global scale.
Website visit project website
Network JPI AMR
Call 8th Joint Call of JPIAMR

Project partner

Number Name Role Country
1 Jacobs University Bremen Coordinator Germany
2 Fraunhofer Institute for Molecular Biology and Applied Ecology Observer Germany
3 The Pew Charitable Trusts Observer USA
4 University of Cagliari Observer Italy
5 University of Barcelona Observer Spain
6 Biotechnologie et Signalisation Cellulaire Observer France
7 Université Catholique de Louvain Observer Belgium
8 University of Oklahoma Observer USA
9 Beckman Institute for Advanced Science and Technology Observer USA
10 Memorial Sloan Kettering Cancer Center Observer USA
11 Fundación MEDINA Observer Spain
12 Theodor Bilharz Research Institute Observer Egypt
13 The Weizmann Institute of Science Observer Israel
14 EU-OPENSCREEN ERIC Observer Germany
15 Institute of Bioorganic Chemistry, Polish Academy of Sciences Observer Poland
16 INSERM Observer France
17 University of Bergen Observer Norway
18 University Hospitals Geneva Observer Switzerland
19 Latvian Institute of Organic Synthesis Observer Latvia
20 Ankara University Observer Turkey
21 Palacky University Olomouc Observer Czech Republic
22 University of Helsinki Observer Finland